Australian Bureau of Statistics figures suggest there have been more than 800 ‘excess deaths’ in Australia in January-March 2020, relative to the average, but only 103 confirmed COVID-19 deaths so far.
Articles on Respiratory infections
Displaying 21 - 23 of 23 articles
Scientists do not yet know the severity of the current coronavirus. A biologist who worked on the 2009 flu pandemic offers insights on that outbreak as well as the SARS outbreak.
A drug called palivizumab can keep babies infected with respiratory syncytial virus (RSV) out of the hospital, but many Inuit babies, who have a higher risk of infection, are not getting it.
Top contributors
-
Ph.D. Candidate in Immunology, University of Virginia
-
Professor of Medicine, University of East Anglia
-
Professor, Cumming School of Medicine, University of Calgary
-
Medical Student, University of Calgary
-
Honorary Professor, Epidemiology, UCL
-
Associate Professor Pediatrics and Dalla Lana School of Public Health, Chair Indigenous Health Conference, North American Refugee Health Conference, University of Toronto
-
Associate Professor and Research Leader in Virology and Infectious Disease, Griffith University
-
Associate Professor of Epidemiology, Texas A&M University
-
Senior Principal Research Fellow; paediatrician; infectious diseases epidemiologist; vaccinologist, The University of Melbourne
-
Research Assistant at Department of Critical Care Medicine, University of Calgary
-
Research Fellow, Institute for Glycomics, Griffith University
-
Assistant Professor in the Department of Medicine, University of Calgary
-
Associate Professor, Department of Geography, Environment and Geomatics, University of Guelph
-
Professor of Family Medicine, University of Calgary
-
Chair in Epidemiology, Deakin University